Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TCT Highlights: Late Stent Thrombosis Controversy Continues

Executive Summary

Late stent thrombosis (LST) concerns associated with drug-eluting stents (DES) dominated sessions at the 2006 Transcatheter Cardiovascular Therapeutics (TCT) annual conference, with additional long-term data presented on this topic. The general feeling expressed was one of relief that the expanded dataset presented at TCT showed the LST problem was not as bad as some had feared when the issue was discussed at the World Congress of Cardiology (WCC).
Advertisement

Related Content

COURAGE Trial: Bad News Again for Stents at ACC, Or Is It?
Bifurcation Stenting: The Next Generation
At TCT, DES Use and Safety Concerns: Irrational Exuberance or Irrational Anxiety?
OrbusNeich: Tissue Engineering Meets Coronary Stents
X-Cell Medical: Putting Safety First
Labcoat: Less is more in Next Generation Drug-Eluting Stents
Hemoteq's Fancy New Coat
Abbott Vascular: The Now-Ready-For-Prime-Time Player
At TCT, A New Vision of the Device Industry
At PCR, Drug-Eluting Stents Dominate the Discussion

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT035036

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel